B-Logic Therapeutics

Biotechnology Research • St Louis, Missouri, United States • 1-10 Employees

Company overview

Headquarters	4340 Duncan Ave, St Louis, Missouri 63110, US
NAICS	541714
Keywords	Gene Therapy, Cell Therapy, Cell Engineering, Vectorology
Founded	2024
Employees	1-10

Key Contact at B-Logic Therapeutics

David T. Curiel

Founder

About B-Logic Therapeutics

B-Logic is a pre-seed stage biotechnology company with a mission to revolutionize patient access to cell and gene therapies. Our fully modular adenoviral vector platform efficiently and specifically delivers genetic engineering machinery to practically any cell type, in vivo or ex vivo. Our high capacity adenoviral vector has vast applications ranging from oncology to genetic diseases to infectious diseases. With limitless use cases and radically simplified manufacturing, B-Logic’s adenoviral vector platform is the logical next generation cell engineering platform. For more information, contact our team at pboucher@blogictx.com.

B-Logic Therapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

B-Logic Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

B-Logic Therapeutics has never raised funding before.

Frequently asked questions

B-Logic Therapeutics is located in St Louis, Missouri, US.

B-Logic Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

B-Logic Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at B-Logic Therapeutics

David T. Curiel

Founder

4.8

40,000 users